We concluded the different PDT efficacy in vivo that nanocarrier could improve the water-solubility and bioavailability of HA and TFR-mediated endocytic pathway could improve the cellular uptake of TF-modified nanoparticles within TFR positive cancer cells (Han et al., 2014; Guo et al., 2017). The gene discussed is TF; the disease is cancer.